EU Medtech Forum 2013: New rules, new markets
This article was originally published in Clinica
The annual European Medtech Forum has always promised to be a hotbed for debate over key EU medtech regulatory issues. But with this year’s meeting – entitled New Rules, New markets – taking place just two weeks after the milestone 25 September vote by EU Parliament committee ENVI on the proposed Medical Device and IVD Regulations, opinions were voiced with a renewed sense of purpose and urgency as industry, healthcare professionals, patients’ representatives and, of course, the policy-makers convened to make their views heard.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.